24/7 Market News Snapshot 11 September, 2025 – Amesite Inc. (NASDAQ:AMST)

September 11, 2025

DENVER, Colo., 11 September, 2025 (www.247marketnews.com) – (NASDAQ:AMST) are discussed in this article.
Amesite Inc. is experiencing remarkable momentum in the financial markets, with its stock trading at $4.175—up 55.78% from the previous close of $2.680 in pre-market trading. This significant increase, driven by a trading volume of 2.52 million shares, highlights the growing investor enthusiasm surrounding the company, marking it as a notable player in the market.

In parallel, Amesite has announced a remarkable 63% revenue growth from its NurseMagic™ platform, signifying a transformative shift in healthcare technology. This growth follows the introduction of its enterprise subscription model on July 14, 2025, which is rapidly surpassing direct-to-consumer sales, reflecting a burgeoning demand from post-acute care providers for scalable and compliant technological solutions.

Brandon Owens, Vice President of Sales at Amesite, remarked, “We’re no longer just selling to employees; we’re serving every patient in the system and empowering organizations to utilize AI technology as a crucial competitive advantage.” This shift indicates that Amesite’s total addressable market is expanding significantly, with healthcare providers increasingly opting for NurseMagic™ Enterprise to improve operational efficiencies without the need for additional staffing.

The impending mandate from the Centers for Medicare & Medicaid Services (CMS) concerning the Hospice Outcomes and Patient Evaluation (HOPE) assessment is placing greater demands on organizations for documentation. Amesite’s AI-enhanced features within NurseMagic™ Enterprise are strategically designed to alleviate these challenges by streamlining complex government forms, thus diminishing administrative workloads and securing full reimbursement capabilities.

Dr. Ann Marie Sastry, CEO of Amesite, highlighted that the platform is reconfiguring how post-acute care organizations can adeptly manage regulatory requirements, serving as an essential tool for clients amid a competitive landscape. As the post-acute care sector continues to expand—with an 8% compound annual growth rate—Amesite is poised to redefine care delivery and operational performance through its AI-driven solutions, catering to an increasingly growing market.

Related news for (AMST)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.